The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...

Children with nonsystemic juvenile idiopathic arthritis who initiated TNF inhibitors when aged 2 years or less showed significant and sustained improvements in disease activity. Early initiation of ...

While the link between TNF inhibitor use during pregnancy/postpartum and serious infection risk was not statistically significant, an increased risk cannot be ruled out.

Please provide your email address to receive an email when new articles are posted on . There were “no significant differences” in efficacy, safety or adherence for TNF inhibitors between young- and ...

Changing the mechanism of action may offer more durable disease control for patients with PsA who do not respond to an initial TNF inhibitor.

Please provide your email address to receive an email when new articles are posted on . Switching from a TNF inhibitor to upadacitinib was superior to cycling TNF inhibitors. Upadacitinib outcomes ...

Patients with axial spondyloarthritis (axSpA) treated with tumor necrosis factor (TNF) inhibitors were at significantly lower risk for hip and spine fractures compared with those receiving only ...

TNF inhibitors were used by 64% of pregnant women with inflammatory diseases through all trimesters. Those with continuous use through all trimesters had reduced use of corticosteroids postpartum.

In utero exposure to TNF inhibitors among offspring born to mothers with chronic inflammatory diseases was not associated with an increased risk for serious infections. However, among those exposed to ...

In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...